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A B S T R A C T
During August and September 2012, seven cases of West Nile neuroinvasive disease were identified in three north-
-eastern counties of Croatia. Four cases were reported in Osijek-Baranja County, two in Brod-Posavina County and one
in Vukovar-Srijem County. The median age of the patients was 62.7 years. All patients were hospitalized for 2–5 weeks.
The patients from Slavonski Brod had more severe clinical presentation of disease with prolonged hospitalization. Medi-
cal entomological research was carried out in 64 localities, where 1785 mosquitoes were captured. Among the analyzed
mosquitoes, 114 were determined to be Culex pipiens and subjected to molecular characterization for the presence of vi-
rus. No viral RNA was detected in mosquitoes. Subsequent public health measures taken include mosquito control in all
settlements where disease was detected.
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Introduction
The spreading of West Nile virus (WNV) has been ob-
served in south-eastern parts of Europe, and human in-
fections have been recorded. Human infections have
been reported in Italy, Hungary and Romania1–3 that are
in close proximity to Croatia. The actual incidence of
WNV in Europe remains under investigation. However,
human cases of West Nile neuroinvasive disease (WNND),
which can be fatal, have been reported. Nevertheless, a
majority of infections are not likely detected since it is es-
timated that up to 80% of WNV human infections are
asymptomatic. In Croatia, past serological studies for
WNV infection revealed a seroprevalence of 3% in inhab-
itants of several Croatian islands4. During 2010, WNV
was found in horses in nearly all of the lowland counties
of Croatia, as well as in Istria County5. It is now evident
that the virus has spread in the lowland parts of Croatia.
While birds are the main reservoir, potential vectors in
Croatia are Culex pipiens (Cx. pipiens) complex, Aedes
vexans (Ae. vexans), Ochlerotatus caspius (Oc. caspius),
Ochlerotatus cantans (Oc. cantans), Anopheles maculi-
pennis and Aedes cinereus (Ae. cinereus). According to ex-
isting literature6, Cx. pipiens pipiens var. molestus is the
most capable vector with a high vector capacity, because
feeding of this species includes birds, humans and hor-
ses. Although 2012 was a considerably dry year with a
lower total number of mosquitoes in the Slavonia region
(northeast Croatia), environmental conditions still facili-
tated spread of WNV, subsequently leading to human in-
fection.
Following an outbreak of WNV in Greece7 and Roma-
nia in 20103, and especially due to recent outbreak in
Serbia in 2012, surveillance for WNND was enhanced in
Croatia. All health authorities were asked to increase
their vigilance. In addition, a history of travel to Serbia
was added as part of the case definition for WNND.
Materials and Methods
Detection of specific antibodies against
West Nile virus in patients
Serum samples of seven patients were tested for the
presence of IgM and IgG antibodies in National Refer-
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ence Laboratory for Arboviruses and Rickettsioses, Cro-
atian Public Health Institute, Zagreb. Laboratory diag-
nosis was confirmed using a plaque reduction neutra-
lization test (PRNT) at the OIE Reference Laboratory
for West Nile Virus at the Istituto G. Caporale (Teramo,
Italy).
Mosquito sampling
Sampling of mosquitoes in 64 localities in three east-
ern counties of Croatia was done using CDC traps baited
with dry ice. Mosquitoes were collected from the 10th to
25th of September. Traps operated 12 hours, starting in
late afternoon. The sampling of mosquitoes in the city of
Osijek was carried out under the regular mosquito moni-
toring program. A total of 114 Cx. pipiens mosquitoes
were stored in a deep freezer at –80 oC until further anal-
ysis.
West Nile virus detection in mosquitoes
Mosquitoes were pooled according to place of origin
and titrated in Minimum Essential Medium. Total RNA
was isolated from a 200 mL aliquot of the tissue homoge-
nate after addition of 800 mL TriPure. After transcrip-
tion into cDNA, semi-nested pan-Flavivirus PCR [8] was
used to amplify viral RNA.
Outbreak Case Description
On the 4th August 2012, the first suspected case was
hospitalized in Slavonski Brod General Hospital. Medical
history showed that the patient had travelled recently to
Serbia before the onset of disease, indicating that the in-
fection was most likely acquired in Serbia and, thus, may
be considered an imported case. The third patient de-
clared that the infection has established due to incidental
contact with bird faeces and eye conjunctiva, but mos-
quito bite also cannot be excluded. Both cases were from
Brod-Posavina County, where mosquito abundance was
extremely low. In Osijek-Baranja and Vukovar-Srijem
County, five patients (Table 1, case 2, 4, 5, and 7) were
hospitalised in Osijek Universtiy hospital. The patient
declared mosquito bites, but not tick bites. All the pa-
tients were treated symptomatically. The patients from
Slavonski Brod (case 1 and 3) had more severe clinical
presentation of disease with prolonged hospitalization
(45 and 34 days, respectively). Furthermore, they devel-
oped neurologic sequels, which required further treat-
ment. The patients from Osijek University Hospital had
moderate clinical presentation of disease and were re-
leased after 2 to 3 weeks without obvious chronic sequels
at the time of this analysis.
The first confirmed WNND case appeared on the 4th
August 2012 and the last one on 15th September 2012. All
of them had high IgM ranged from 1.7–4.1 (POZ if >1.1),
IgG ranged from 40–132 (POZ if >22 RU/mL). Cases 5
and 7 had negative IgG because serum was taken in the
beginning of hospitalization. The sex ratio (male: female)
was 3:4. The median age was 62.7 years (age range:
48–77 years). Most cases (n=3) occurred in the 60–69
year old age group (Table 1). Out of 7 cases, two of them
lived in urban settings and 5 in rural areas, giving an ur-
ban: rural ratio of 2:5.
Neurological symptoms in 5 patients from Osijek hos-
pital were: disturbance of consciousness (apathy, somno-
lent), restlessness, irritability, hallucinations, general
tremors and hyperesthesia. Body temperature rose in all
patients between day 3–6, ranging from 38–38.5 °C.
Other symptoms included headache, nausea, vomit and
photophobia. Cerebrospinal fluid (CSF) was clear, con-
taining 10–517 leucocytes (lymphocytes 15–75%, mono-
cytes 3–23%, neutrophilus 2–82%). Patient EEGs were
diffusely dysrhythmic or sideways dysrhythmic.
Two patients from Slavonski Brod (cases 1 and 3 in
Table 1) had more severe course of disease of WNND,
and full report of these cases can be found below.
The first patient was a previously healthy 65 year old
male. On August 12th, he was admitted to the hospital
after a persistent 7-day fever and headache. He com-
plained of malaise, weakness, nausea and lack of appe-
tite. Upon admission, he was febrile with a temperature
of 38 °C and a pulse rate of 98 beats/min, blood pressure
of 130/80 mm Hg and respiratory rate of 18 breaths/min.
He presented as a mildly ill patient. He was alert and ori-
ented. There were no meningeal signs present and the
physical examination was unremarkable. His leukocyte
count was 14.30x109/L with 84% neutrophils, 11% lym-
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TABLE 1




Age Sex Place County
Day of taking
the serum
1. 4. Aug. (7) 65 M Slavonski Brod Brod-Posavina 30.
2. 20. Aug. (4) 48 F Budimci Osijek-Baranja 21.
3. 25. Aug. (6) 60 F Slavonski Brod Brod-Posavina 19.
4. 26. Aug. (3) 77 F Vukovar Vukovar-Srijem 15.
5. 4. Sep. (3) 76 M Beli{}e Osijek-Baranja 6.
6. 12. Sep. (5) 48 F Ku{evac Osijek-Baranja 13.
7. 15. Sep. (6) 65 M Petrijevci Osijek-Baranja 8.
* Numbers in parentheses in second colon represent days with the symptoms of disease before hospitalization
phocytes and 4% monocytes. Lab reports indicated 4.89 x
1012/L red blood cells and 187 x 10e9/L platelets count.
Serum transaminases were slightly elevated: AST 43 U/L
(normal range 11–38 U/L) and ALT 65 U/L (normal
range 12–48 U/L). CRP was 18.7 mg/L (normal range <5
mg/L). Other results of serum laboratory analysis were
within normal ranges. Lumbar puncture (LP) was per-
formed and his cerebrospinal fluid (CSF) was clear, con-
taining 380 leucocytes and 160 erythrocytes per mm3.
CSF glucose level was 2.9 mmol/L and protein level was
1.81 g/L (normal range 0.17–0.37 g/L). No abnormalities
were seen on the brain CT scan. On the fourth day of his
hospitalization, he became somnolent and dysarthric.
Furthermore, flaccid paraparesis occurred. The next day,
paraparesis deteriorated to lower limb flaccid paralysis,
and right arm flaccid paralysis also occurred. His EEG
was diffusely dysrhythmic with slow theta rhythm. Elec-
tromyography detected mixed motor polyneuropathy,
particularly in lower limbs. Then he became afebrile but,
after one week, he developed pneumonia and was febrile
again. Although improvement was slow, he was dischar-
ged from the hospital and referred to a physical therapy
institution.
Case 3 was a 60 year old female with a previous his-
tory of mild hypertension. She was admitted to the hospi-
tal on the 6th day of her illness and presented with nau-
sea, vomiting and left arm tremor. On the 5th day of her
illness, she became febrile and complained of headache,
myalgias and decreased appetite. During hospital admis-
sion, she was febrile with a temperature of 38.5 °C, and
blood pressure was 160/85 mm Hg with a pulse rate of 94
beats/min. She was tachypneic with a respiratory rate of
30 breaths/min and blood oxygen saturation of 94%. Her
physical examination was normal with no neck rigidity.
Laboratory tests showed that leucocytes count was 9.94 x
109/L with 77% neutrophils, 14% lymphocytes and 9%
monocytes. CRP was 4.6 mg/L (normal range <5 g/L). LP
was done and her CSF was clear. CSF protein level was
0.96 g/L (normal range 0.17–0.37 g/L). On the second day
of hospitalization, flaccid paralysis of her left arm oc-
curred and, at the same time, she became confused.
Brain CT scan was normal and EEG was diffusely dys-
rhythmic with slow theta rhythm. The next day, periph-
eral facial nerve paralysis occurred. From admission, she
was treated with symptomatic therapy only. Over the
next week, her consciousness slowly improved and she
became afebrile, so physical therapy was started. After
28 days of hospitalization, she was discharged and re-
ferred to a physical therapy institution.
Medical entomological study
Immediately after the first human case of WNND,
sampling of mosquitoes was organized. A total of 1785
mosquitoes were caught. The number of sampling places
differed from county to county. In Osijek-Baranja Coun-
ty, Vukovar-Srijem County and Brod-Posavina County,
there were 43, 17 and 4 sampling sites, respectively
(Figure 1). In villages where WNND cases originated
(Budimci and Beli{}e), 4 CDC traps were set up, and one
of those being in the backyard of one WNND patient. Ae.
vexans comprised of 1634 specimens (91.54%), while 114
specimens (6.39%) were determined to be Cx. pipiens
complex. Species distribution was normal for this part of
the year (Table 2). All Cx. pipiens complex specimens
tested using pan-Flavivirus PCR were negative for WNV.
Public health measures
Surveillance in Croatia had been gradually increased
following reports of the outbreak of WNV in Serbia and
subsequent confirmation of the first case of human infec-
tion in Croatia. The Ministry of Health and public health
authorities organized several meetings and recommen-
ded mosquito control measures. The Public Health Insti-
tute of Osijek-Baranja County organized mosquito con-
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Fig. 1. Distribution of WNND human cases and places of mos-
quito sampling in Croatia in 2012.
TABLE 2








Aedes vexans 816 789 26 3
Culex. pipiens 48 39 26 1
Ochlerotatus caspius 16 5 – –
Anopheles maculipennis c. 5 5 2 –
Anopheles hyrcanus 2 1 1 –
TOTAL 887 839 55 4
trol. Larvicide treatment (based on Bti) of 2108 small
water bodies in villages (Budimci, Beli{}e, Vukovar and
Ku{evac) with suspected human cases was carried out
door-to-door from the 18th to 29th of September 2012.
Adulticiding was carried out twice over three days (from
the 20th to 28th of September) at five localities in total of
2900 ha using the ULV method for aerial spraying.
Discussion
The current report described the first documented
WNV outbreak and detection of acute WNV infection in
humans in Croatia. Previously, WNV had been detected
only in horses in eastern Croatia with a seroprevalence
as high as 3.5%5,9. Ongoing research in 2011 and 2012
confirmed the presence of WNV in horses with an even
higher seroprevalence than in 2010 (unpublished data),
meaning that the virus has been present in Croatia for
quite some time. In such circumstances, human infection
was bound to occur. A connection between illness in
horses and humans was established in Andalusia in
201010, indicating that it would be beneficial to investi-
gate the predictive potential of this relationship. Indeed,
disease outbreak in horses may be a precursor for the oc-
currence of the same disease in humans.
Two of seven Croatian patients had a severe form of
WNND with chronic neurologic sequels. Fortunately, no
fatalities were reported during the outbreak in Croatia.
Further follow up and clinical examination of all seven
patients is in process. Consistent with cases from other
countries in Europe1–3, WNND afflicted elderly people in
Croatia with a median age of 62.7 years. Specifically, five
of seven patients were over 60 years of age. Similar to
previous outbreaks in this part of Europe, WNV infection
in humans in Croatia occurred during the late summer
(August–September)1–3.
Over the last three decades, cases of WNV infection
have been reported in humans and horses in the Mediter-
ranean Basin. Most of them were determined to be
strains of the Lineage 1 included in the European Medi-
terranean/Kenyan cluster11. In recent years, however,
the Israeli/American cluster of Lineage 1 and Lineage 2
of WNV have been reported in countries near Croatia,
such as Hungary and Austria11–13. A WNV Lineage 2
strain was also detected in birds and mosquitoes in
Greece during a 2010 WNV outbreak in humans. Phylo-
genetic analysis revealed high sequence similarity
(>99%) with other WNV Lineage 2 strains in Austria
and Hungary (2004–2009)14. The whole genome charac-
terisation of that strain showed that it presented genetic
relationship to the Lineage 2 Hungarian strain, it was
suggested that an amino acid substitution H249P in the
NS3 protein might play a role in the increased pathoge-
nicity of the Greek strain15. A recent study in Serbia
showed that 12% of horses had specific antibodies against
WNV16, followed by an outbreak with severe and fatal
human cases in 201217. In 2012, the first human case of
WNV was confirmed in Kosovo18.
Over the last few years, a significant public health
concern of WNV infection in humans and, especially,
blood donors has been raised in Italy. In summer of 2012,
13 confirmed human cases of WNV were diagnosed in
northern Italy, including patients with neuroinvasive
disease. Five WNV-positive blood donors were confirmed
as well19,20. WNV infection has become an important
topic in relation to blood, tissue and organ safety follow-
ing several reports of contaminated blood supplies and
organs during the WNV outbreak in the United Sta-
tes21,22. Based on data from epidemiological surveillance
of horses and wild birds, as well as reports of human
WNV neuroinvasive infections, blood safety measures in
Italy were established. Specifically, WNV RNA screening
by nucleic acid amplification testing (NAT) of all blood
donations from donors living in the WNV endemic was
introduced23. Despite implementation of NAT screening
of blood donors for WNV, several »breakthrough« WNV
transfusion transmission cases were reported between
2004–2008, suggesting that current plasma-based assays
are unable to detect all WNV-infectious donations and
that additional molecular tests may be required24. As the
first acute cases of WNV in humans in Croatia were re-
ported in 2012, there is no sufficient and relevant epide-
miological data on the spread of WNV among humans,
horses and birds. Furthermore, no compulsory testing
for WNV in blood donors has been introduced. However,
blood donors are temporarily rejected 28 days after leav-
ing in a WNV endemic area.
Out of several potential vectors for WNV in Croatia,
the likeliest vector is Cx. pipiens complex, because other
above mentioned species have low vector capacity. For
this reason, only Cx. pipiens complex specimens were in-
cluded in the analysis and tested for the presence of
WNV. In the fauna of Osijek, this species accounts for
5.86% of the mosquito population measured over pro-
longed period25, which is consistent with results of the
current study (6.39%). In the collected Cx. pipiens com-
plex mosquitoes, no viral WNV RNA was detected. The
small number of tested mosquitoes limits the current
study26. As the summer of 2012 was rather dry, condi-
tions for mosquito breeding were unfavourable, resulting
in a lower total number of mosquitoes. Nevertheless,
other conditions must have influenced and facilitated an
efficient transfer of WNV to humans. Probably high rate
of infected birds, small population of mosquitoes in close
proximity to humans, resulted in human outbreak. Fur-
ther extensive investigations of WNV spreading in hu-
mans, birds and horses are necessary to be done in
Croatia.
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POJAVA BOLESTI KOD LJUDI IZAZVANE VIRUSOM ZAPADNOG NILA
U HRVATSKOJ TIJEKOM 2012.
S A @ E T A K
Tijekom kolovoza i rujna 2012. godine sedam ljudi je oboljelo od neuroinvazivnih bolesti izazvane virusom Zapadnog
Nila u tri sjeveroisto~ne `upanije u Hrvatskoj. Oboljela su ~etiri bolesnika u Osje~ko-baranjskoj, dva u Brodsko-posav-
skoj i jedan u Vukovarsko-srijemskoj `upaniji. Prosje~na starost oboljelih je bila 62,7 godina. Svi pacijenti su hospita-
lizirani od 2 do 5 tjedana. Pacijenti koji su hospitalizirani u bolnici u Slavonskom Brodu imali su te`e klini~ke simptome
te su du`e hospitalizirani. Medicinsko-entomolo{ka istra`ivanja obavljena su na ukupno 64 postaje u sve tri istra`ivanje
`upanije. Od ukupno uhva}enih 1.785 komaraca 144 ih je determinirano kao Cx. pipiens, tj potencijalni prijenosnik
virusa Zapadnog Nila. Molekularnom analizom u tim jedinkama nije prona|ena virusna RNA. U kontekstu sprije~a-
vanja {irenja epidemije organizirana je protuepidemijska dezinsekcija koja se sastojala od larvicidnog i adulticidnog
tretmana u mjestima gdje je zabilje`ena bolest.
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